SCHEMBL6366118

SCHEMBL6366118

COCCCn1cccc1C=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.50
NPC1 O15118 5/20 0.48
RAB9A P51151 5/20 0.48
TRIM24 O15164 1/20 0.47
TRIM33 Q9UPN9 1/20 0.47
GAA P10253 2/20 0.40
CYP1A2 P05177 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MAPT P10636 3/20 0.37
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
ATM Q13315 1/20 0.36
HPGD P15428 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
PTGER4 P35408 1/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
KDM4E B2RXH2 1/20 0.34
GLA P06280 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6366217 0.91 ALDH1A1 (0.46) ALDH1A1NPC1RAB9ATRIM24TRIM33
SCHEMBL3996666 0.90 ALDH1A1 (0.53) ALDH1A1NPC1RAB9ATRIM24TRIM33
SCHEMBL1607919 0.81 TRIM24 (0.52) ALDH1A1NPC1RAB9ATRIM24TRIM33
SCHEMBL11337902 0.79 TRIM24 (0.50) ALDH1A1NPC1RAB9ATRIM24TRIM33
SCHEMBL708367 0.79 ALDH1A1 (0.55) ALDH1A1NPC1RAB9ATRIM24TRIM33
SCHEMBL28897127 0.78 ALDH1A1 (0.46) ALDH1A1NPC1RAB9ATRIM24TRIM33
SCHEMBL9750772 0.78 TRIM24 (0.48) ALDH1A1NPC1RAB9ATRIM24TRIM33
SCHEMBL10852053 0.77 TRIM24 (0.47) ALDH1A1NPC1RAB9ATRIM24TRIM33
SCHEMBL9225514 0.77 TRIM24 (0.55) ALDH1A1NPC1RAB9ATRIM24TRIM33
SCHEMBL6015786 0.76 TRIM24 (0.46) ALDH1A1NPC1RAB9ATRIM24TRIM33

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050250836-A1 Inhibitors of checkpoint kinases (Wee1 and Chk1) PFIZER INC 2005-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050250836-A1 Inhibitors of checkpoint kinases (Wee1 and Chk1) WEE1, WEE2, CHEK1 ALDH1A1 2805/4885NPC1 4059/4885RAB9A 2939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.